0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
ARTICLE |

Renal Failure in Phenazopyridine Overdose

Donald A. Feinfeld, MD; Rosanna Ranieri, MD; Henry I. Lipner, MD; Morrell M. Avram, MD
JAMA. 1978;240(24):2661. doi:10.1001/jama.1978.03290240061030.
Text Size: A A A
Published online

PHENAZOPYRIDINE hydrochloride (Pyridium) is widely used for analgesia of the lower urinary tract. The drug is thought to be safe; information for the prescriber cautions only against its use in renal failure, and a standard textbook of Pharmacology does not mention nephrotoxicity (other than stone formation) or complications of overdose in its section on the drug.1 We report here a case of acute tubular necrosis in a previously healthy adolescent following acute overdosage with phenazopyridine.

Report of a Case  A 13-year-old girl, in prior good health and with a normal developmental history, was admitted to the gastroenterology service with a 24-hour history of yellow skin color and dark urine. On the day of admission, she had had several episodes of vomiting and abdominal cramps. Initial physical findings included normal temperature, pulse rate of 80 beats per minute and regular, and blood pressure of 120/70 mm Hg with no postural

Topics

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

First Page Preview

View Large
First page PDF preview

Figures

Tables

References

CME
Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.

Multimedia

Some tools below are only available to our subscribers or users with an online account.

Sign in

Create a free personal account to sign up for alerts, share articles, and more.

Purchase Options

• Buy this article
• Subscribe to the journal

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs
brightcove.createExperiences();